Other News To Note
• Access Pharmaceuticals Inc., of Dallas, said Rhei Pharmaceuticals HK Ltd., of Hong Kong, its MuGard partner in China, received marketing approval from Chinese regulators for the mucoadhesive oral wound product to treat oral mucositis in cancer patients.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter